https://www.selleckchem.com/products/ag-270.html
No surgical treatment procedure has shown superiority over another; however, individualized treatment is emphasized to improve symptoms and maximize nerve recovery potential. The BIRMINGHAM HIP Resurfacing (BHR) system is a metal-on-metal hip implant system approved by the U.S. Food and Drug Administration in 2006. The approval required a multicenter, prospective, post-market-approval study. Our purpose is to report the current results at 10 years of follow-up. Between October 2006 and December 2009, 280 primary BHR procedures were perfo
Curtir
Comentario
Compartilhar
